Translating clinical research and medical technology innovation into a sustainable company is a complex and far-reaching process. First-time entrepreneurs, clinicians, and engineers often don’t appreciate the importance of the many factors involved—most medical startups fail to commercialize their product and many critical solutions never reach patients. Emerging companies in other sectors face technical and market risks, but medical innovation includes the barriers of regulatory approval, reimbursement, clinical trials, and a complex sales channel strategy. Read the full MPO article here.
תגובות